Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Miliary tuberculosis and acute respiratory distress syndrome.

Boushab BM, Basco LK.

J Clin Tuberc Other Mycobact Dis. 2019 Jun 25;16:100113. doi: 10.1016/j.jctube.2019.100113. eCollection 2019 Aug.

2.

Contribution of Computed Tomography Scan to the Diagnosis of Spinal Tuberculosis in 14 Cases in Assaba, Mauritania.

Boushab BM, Kone N, Basco LK.

Radiol Res Pract. 2019 May 2;2019:7298301. doi: 10.1155/2019/7298301. eCollection 2019.

3.

Long-Term In vitro Cultivation of Plasmodium falciparum in a Novel Cell Culture Device.

Géry A, Basco LK, Heutte N, Guillamin M, N'Guyen HM, Richard E, Garon D, Eldin de Pécoulas P.

Am J Trop Med Hyg. 2019 Apr;100(4):822-827. doi: 10.4269/ajtmh.18-0527.

PMID:
30693863
4.
5.

Malaria, tuberculosis and HIV: what's new? Contribution of the Institut Hospitalo-Universitaire Méditerranée Infection in updated data.

Almeras L, Basco LK, Sokhna C, Ranque S, Parola P, Devaux C, Brouqui P, Drancourt M, Pradines B.

New Microbes New Infect. 2018 Jul 4;26:S23-S30. doi: 10.1016/j.nmni.2018.06.003. eCollection 2018 Nov.

6.

Pyrethroid resistance in the major malaria vector Anopheles arabiensis in Nouakchott, Mauritania.

Mint Mohamed Lemine A, Ould Lemrabott MA, Niang EHA, Basco LK, Bogreau H, Faye O, Ould Mohamed Salem Boukhary A.

Parasit Vectors. 2018 Jun 13;11(1):344. doi: 10.1186/s13071-018-2923-4.

7.

Two Cases of Delayed Diagnosis of Leprosy in Mauritania.

Boushab BM, Fall-Malick FZ, Basco LK.

Case Rep Dermatol Med. 2018 May 16;2018:4394297. doi: 10.1155/2018/4394297. eCollection 2018.

8.

Generalized tetanus in adults without antitetanus booster vaccination in southern Mauritania.

Boushab BM, Fall-Malick FZ, Savadogo M, Basco LK.

Clin Case Rep. 2018 Mar 9;6(5):835-838. doi: 10.1002/ccr3.1470. eCollection 2018 May.

9.

Mucocutaneous manifestations in human immunodeficiency virus (HIV)-infected patients in Nouakchott, Mauritania.

Boushab BM, Malick Fall FZ, Ould Cheikh Mohamed Vadel TK, Ould Cheikh Melaïnine ML, Maazouz MV, Savadogo M, Basco LK.

Int J Dermatol. 2017 Dec;56(12):1421-1424. doi: 10.1111/ijd.13737. Epub 2017 Sep 27.

PMID:
28960268
10.
11.
12.

Forms of Stigma and Discrimination in the Daily Lives of HIV-Positive Individuals in Mauritania.

Boushab BM, Fall-Malick FZ, Ould Cheikh Melaïnine ML, Basco LK.

Open AIDS J. 2017 Mar 31;11:12-17. doi: 10.2174/1874613601711010012. eCollection 2017.

13.

[Role of primaquine in malaria control and elimination in French-speaking Africa].

Briolant S, Pradines B, Basco LK.

Bull Soc Pathol Exot. 2017 Aug;110(3):198-206. doi: 10.1007/s13149-017-0556-z. Epub 2017 Apr 17. Review. French.

PMID:
28417346
14.

Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.

Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H.

Malar J. 2017 Apr 5;16(1):140. doi: 10.1186/s12936-017-1791-2.

15.

Reemergence of chloroquine-sensitive pfcrt K76 Plasmodium falciparum genotype in southeastern Cameroon.

Ndam NT, Basco LK, Ngane VF, Ayouba A, Ngolle EM, Deloron P, Peeters M, Tahar R.

Malar J. 2017 Mar 27;16(1):130. doi: 10.1186/s12936-017-1783-2.

16.

Hidden reservoir of resistant parasites: the missing link in the elimination of falciparum malaria.

Abdul-Ghani R, Mahdy MA, Beier JC, Basco LK.

Infect Dis Poverty. 2017 Feb 6;6(1):12. doi: 10.1186/s40249-016-0227-5.

17.

Severe Human Illness Caused by Rift Valley Fever Virus in Mauritania, 2015.

Boushab BM, Fall-Malick FZ, Ould Baba SE, Ould Salem ML, Belizaire MR, Ledib H, Ould Baba Ahmed MM, Basco LK, Ba H.

Open Forum Infect Dis. 2016 Sep 27;3(4):ofw200. eCollection 2016 Oct.

18.

Acute kidney injury in a shepherd with severe malaria: a case report.

Boushab BM, Fall-Malick FZ, Savadogo M, Basco LK.

Int J Nephrol Renovasc Dis. 2016 Oct 11;9:249-251. eCollection 2016.

19.

Efficacy of sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in southern Mauritania.

Ouldabdallahi MM, Sarr O, Basco LK, Lebatt SM, Lo B, Gaye O.

Med Sante Trop. 2016 Aug 1;26(3):297-301.

20.

Plasma levels of eight different mediators and their potential as biomarkers of various clinical malaria conditions in African children.

Tahar R, Albergaria C, Zeghidour N, Ngane VF, Basco LK, Roussilhon C.

Malar J. 2016 Jun 29;15:337. doi: 10.1186/s12936-016-1378-3.

21.

Malaria in three epidemiological strata in Mauritania.

Ouldabdallahi Moukah M, Ba O, Ba H, Ould Khairy ML, Faye O, Bogreau H, Simard F, Basco LK.

Malar J. 2016 Apr 12;15:204. doi: 10.1186/s12936-016-1244-3.

22.

Malaria burden and anti-malarial drug efficacy in Owando, northern Congo.

Singana BP, Bogreau H, Matondo BD, Dossou-Yovo LR, Casimiro PN, Mbouka R, Ha Nguyen KY, Pradines B, Basco LK, Ndounga M.

Malar J. 2016 Jan 8;15:16. doi: 10.1186/s12936-015-1078-4.

23.

Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study.

Ndounga M, Pembe Issamou Mayengue, Casimiro PN, Koukouikila-Koussounda F, Bitemo M, Diassivy Matondo B, Ndounga Diakou LA, Basco LK, Ntoumi F.

Malar J. 2015 Oct 29;14:423. doi: 10.1186/s12936-015-0918-6.

24.

Inclusion of gametocyte parameters in anti-malarial drug efficacy studies: filling a neglected gap needed for malaria elimination.

Abdul-Ghani R, Basco LK, Beier JC, Mahdy MA.

Malar J. 2015 Oct 19;14:413. doi: 10.1186/s12936-015-0936-4.

25.

Malaria-associated morbidity during the rainy season in Saharan and Sahelian zones in Mauritania.

Ould Ahmedou Salem MS, Basco LK, Ouldabdallahi M, Mint Lekweiry K, Konaté L, Faye O, Ould Mohamed Salem Boukhary A.

Acta Trop. 2015 Dec;152:1-7. doi: 10.1016/j.actatropica.2015.08.005. Epub 2015 Aug 11.

PMID:
26276697
26.

Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.

Foumane Ngane V, Allico Djaman J, Culeux C, Piette N, Carnevale P, Besnard P, Fortes F, Basco LK, Tahar R.

Malar J. 2015 Mar 14;14:113. doi: 10.1186/s12936-015-0634-2.

27.

Malaria in Mauritania: retrospective and prospective overview.

Lekweiry KM, Salem MS, Basco LK, Briolant S, Hafid J, Boukhary AO.

Malar J. 2015 Mar 4;14:100. doi: 10.1186/s12936-015-0607-5. Review.

28.

Efficacy of chloroquine for the treatment of Plasmodium vivax in the Saharan zone in Mauritania.

Ould Ahmedou Salem MS, Mohamed Lemine YO, Deida JM, Lemrabott MA, Ouldabdallahi M, Ba MD, Boukhary AO, Khairy ML, Abdel Aziz MB, Ringwald P, Basco LK, Niang SD, Lebatt SM.

Malar J. 2015 Jan 28;14:39. doi: 10.1186/s12936-015-0563-0.

29.

Increasing prevalence of Plasmodium vivax among febrile patients in Nouakchott, Mauritania.

Ould Ahmedou Salem MS, Mint Lekweiry K, Mint Deida J, Ould Emouh A, Ould Weddady M, Ould Mohamed Salem Boukhary A, Basco LK.

Am J Trop Med Hyg. 2015 Mar;92(3):537-40. doi: 10.4269/ajtmh.14-0243. Epub 2015 Jan 12.

30.

Efficacy of artesunate-amodiaquine for the treatment of acute uncomplicated falciparum malaria in southern Mauritania.

Ouldabdallahi M, Alew I, Salem MS, Dit Dialaw Ba M, Boukhary AO, Khairy ML, Aziz MB, Ringwald P, Basco LK, Niang SD, Lebatt SM.

Malar J. 2014 Dec 16;13:496. doi: 10.1186/1475-2875-13-496.

31.

Differences in gene transcriptomic pattern of Plasmodium falciparum in children with cerebral malaria and asymptomatic carriers.

Almelli T, Nuel G, Bischoff E, Aubouy A, Elati M, Wang CW, Dillies MA, Coppée JY, Ayissi GN, Basco LK, Rogier C, Ndam NT, Deloron P, Tahar R.

PLoS One. 2014 Dec 5;9(12):e114401. doi: 10.1371/journal.pone.0114401. eCollection 2014.

32.

Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children.

Tahar R, Almelli T, Debue C, Foumane Ngane V, Djaman Allico J, Whegang Youdom S, Basco LK.

J Infect Dis. 2014 Dec 15;210(12):1962-71. doi: 10.1093/infdis/jiu341. Epub 2014 Jun 18.

PMID:
24943722
33.

Population genetics analysis during the elimination process of Plasmodium falciparum in Djibouti.

Khaireh BA, Assefa A, Guessod HH, Basco LK, Khaireh MA, Pascual A, Briolant S, Bouh SM, Farah IH, Ali HM, Abdi AI, Aden MO, Abdillahi Z, Ayeh SN, Darar HY, Koeck JL, Rogier C, Pradines B, Bogreau H.

Malar J. 2013 Jun 13;12:201. doi: 10.1186/1475-2875-12-201.

34.

Artesunate-amodiaquine efficacy in Congolese children with acute uncomplicated falciparum malaria in Brazzaville.

Ndounga M, Mayengue PI, Casimiro PN, Loumouamou D, Basco LK, Ntoumi F, Brasseur P.

Malar J. 2013 Feb 5;12:53. doi: 10.1186/1475-2875-12-53.

35.

Clinical efficacy of artemether-lumefantrine in congolese children with acute uncomplicated falciparum malaria in brazzaville.

Ndounga M, Tahar R, Casimiro PN, Loumouamou D, Basco LK.

Malar Res Treat. 2012;2012:749479. doi: 10.1155/2012/749479. Epub 2012 Dec 17.

36.

Field evaluation of rapid diagnostic tests for malaria in Yaounde, Cameroon.

Tahar R, Sayang C, Ngane Foumane V, Soula G, Moyou-Somo R, Delmont J, Basco LK.

Acta Trop. 2013 Feb;125(2):214-9. doi: 10.1016/j.actatropica.2012.10.002. Epub 2012 Oct 17.

PMID:
23085326
37.

Multiple treatment comparisons in a series of anti-malarial trials with an ordinal primary outcome and repeated treatment evaluations.

Whegang Youdom S, Samson A, Basco LK, Thalabard JC.

Malar J. 2012 May 3;11:147. doi: 10.1186/1475-2875-11-147.

38.

Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.

Menard S, Morlais I, Tahar R, Sayang C, Mayengue PI, Iriart X, Benoit-Vical F, Lemen B, Magnaval JF, Awono-Ambene P, Basco LK, Berry A.

Malar J. 2012 Apr 12;11:113. doi: 10.1186/1475-2875-11-113.

39.

Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania.

Mint Lekweiry K, Ould Mohamed Salem Boukhary A, Gaillard T, Wurtz N, Bogreau H, Hafid JE, Trape JF, Bouchiba H, Ould Ahmedou Salem MS, Pradines B, Rogier C, Basco LK, Briolant S.

J Antimicrob Chemother. 2012 Feb;67(2):367-74. doi: 10.1093/jac/dkr464. Epub 2011 Nov 14.

PMID:
22086859
40.

Vivax malaria in Mauritania includes infection of a Duffy-negative individual.

Wurtz N, Mint Lekweiry K, Bogreau H, Pradines B, Rogier C, Ould Mohamed Salem Boukhary A, Hafid JE, Ould Ahmedou Salem MS, Trape JF, Basco LK, Briolant S.

Malar J. 2011 Nov 3;10:336. doi: 10.1186/1475-2875-10-336.

41.

Malaria prevalence and morbidity among children reporting at health facilities in Nouakchott, Mauritania.

Lekweiry KM, Basco LK, Salem MS, Hafid JE, Marin-Jauffre A, Weddih AO, Briolant S, Bogreau H, Pradines B, Rogier C, Trape JF, Boukhary AO.

Trans R Soc Trop Med Hyg. 2011 Dec;105(12):727-33. doi: 10.1016/j.trstmh.2011.09.004. Epub 2011 Oct 21.

PMID:
22019287
42.

In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (Côte d'Ivoire).

Yavo W, Bla KB, Djaman AJ, Assi SB, Basco LK, Mazabraud A, Koné M.

Afr Health Sci. 2010 Jun;10(2):111-6.

43.

Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs.

Pascual A, Basco LK, Baret E, Amalvict R, Travers D, Rogier C, Pradines B.

Malar J. 2011 Jan 14;10:8. doi: 10.1186/1475-2875-10-8.

44.

Analysis of an ordinal outcome in a multicentric randomized controlled trial: application to a 3- arm anti- malarial drug trial in Cameroon.

Whegang SY, Basco LK, Gwét H, Thalabard JC.

BMC Med Res Methodol. 2010 Jun 18;10:58. doi: 10.1186/1471-2288-10-58.

45.

Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon.

Whegang SY, Tahar R, Foumane VN, Soula G, Gwét H, Thalabard JC, Basco LK.

Malar J. 2010 Feb 19;9:56. doi: 10.1186/1475-2875-9-56.

46.
48.

[Malaria in health centres in the southern districts of Brazzaville, Congo].

Ndounga M, Casimiro PN, Miakassissa-Mpassi V, Loumouamou D, Ntoumi F, Basco LK.

Bull Soc Pathol Exot. 2008 Oct;101(4):329-35. French.

PMID:
18956816
49.

Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistance alleles in a population from central Africa.

McCollum AM, Basco LK, Tahar R, Udhayakumar V, Escalante AA.

Antimicrob Agents Chemother. 2008 Nov;52(11):4089-97. doi: 10.1128/AAC.00623-08. Epub 2008 Sep 2.

50.

Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.

Ndounga M, Tahar R, Basco LK, Casimiro PN, Malonga DA, Ntoumi F.

Trop Med Int Health. 2007 Oct;12(10):1164-71.

Supplemental Content

Loading ...
Support Center